Related Experiment Video
Updated: Mar 13, 2026
06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
9.3K
The 2016 ACCP Pharmacotherapy Didactic Curriculum Toolkit
Terry L Schwinghammer1, Andrew J Crannage1, Eric G Boyce1
1American College of Clinical Pharmacy.
Pharmacotherapy
|November 3, 2016
Summary
The updated Pharmacotherapy Didactic Curriculum Toolkit guides pharmacy schools in curriculum development. It categorizes 276 topics into tiers based on practice competency, emphasizing foundational knowledge and postgraduate training needs.
Area of Science:
- Pharmacy Education
- Pharmacotherapy
- Curriculum Development
Background:
- The American College of Clinical Pharmacy (ACCP) Educational Affairs Committee updated its 2009 Pharmacotherapy Didactic Curriculum Toolkit in 2016.
- The toolkit aims to assist pharmacy schools in creating, maintaining, and revising their educational programs.
Purpose of the Study:
- To contemporize the ACCP's Pharmacotherapy Didactic Curriculum Toolkit.
- To identify and organize disease states and content topics responsive to drug therapy for pharmacy curricula.
Main Methods:
- Reviewed recent medical literature and relevant documents.
- Organized identified disease states and content topics by organ system.
- Grouped topics into three tiers based on practice competency levels.
Main Results:
- The 2016 toolkit includes 276 diseases and content topics.
- Tier 1 (foundational): 87 topics (32%) for immediate post-graduation patient care.
- Tier 2 (intermediate): 133 topics (48%) often requiring postgraduate training.
- Tier 3 (advanced): 56 topics (20%) typically requiring self-study post-graduation.
Conclusions:
- The updated toolkit provides a comprehensive framework for pharmacotherapy education.
- A significant number of Tier 1 topics necessitate innovative teaching strategies for competency.
- The high proportion of Tier 2 topics underscores the critical role of residency training for advanced patient care skills.
Related Concept Videos
01:28Dosage Regimens: Designs and Approaches
434
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
434
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
57
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
57
01:26Drug Administration and Therapy Phases: Overview
1.6K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.6K
01:27Coronary Artery Disease V: Interprofessional Care
358
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
358
01:27Peripheral Artery Disease III: Interprofessional Care
486
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
486
01:20Desensitization and Tachyphylaxis
3.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K